BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11559529)

  • 1. Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor.
    Fujimori M; Ikeda S; Shimizu Y; Okajima M; Asahara T
    Cancer Res; 2001 Sep; 61(18):6656-9. PubMed ID: 11559529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear translocation of beta-catenin protein but absence of beta-catenin and APC mutation in gastrointestinal carcinoid tumor.
    Su MC; Wang CC; Chen CC; Hu RH; Wang TH; Kao HL; Jeng YM; Yuan RH
    Ann Surg Oncol; 2006 Dec; 13(12):1604-9. PubMed ID: 17009161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway.
    Torbenson M; Lee JH; Choti M; Gage W; Abraham SC; Montgomery E; Boitnott J; Wu TT
    Mod Pathol; 2002 Mar; 15(3):189-96. PubMed ID: 11904335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability.
    Fukushima H; Yamamoto H; Itoh F; Horiuchi S; Min Y; Iku S; Imai K
    J Exp Clin Cancer Res; 2001 Dec; 20(4):553-9. PubMed ID: 11876551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
    Chen YW; Jeng YM; Yeh SH; Chen PJ
    Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.
    Clements WM; Wang J; Sarnaik A; Kim OJ; MacDonald J; Fenoglio-Preiser C; Groden J; Lowy AM
    Cancer Res; 2002 Jun; 62(12):3503-6. PubMed ID: 12067995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
    Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
    Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.
    Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Grieco M; Ramires P; Romito AM; De Rosa G; Piattelli A
    Anticancer Res; 2002; 22(2A):565-76. PubMed ID: 12014624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
    Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
    Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
    Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
    Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
    Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
    Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J
    Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APC mutations are infrequent but present in human lung cancer.
    Ohgaki H; Kros JM; Okamoto Y; Gaspert A; Huang H; Kurrer MO
    Cancer Lett; 2004 Apr; 207(2):197-203. PubMed ID: 15072829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
    Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
    Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation.
    Saegusa M; Okayasu I
    J Pathol; 2001 May; 194(1):59-67. PubMed ID: 11329142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
    Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
    Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
    Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE
    Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
    Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
    Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.